TrialRheumatology (Oxford, England)2016

Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis.

Bruce Kirkham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.